Vulnerabilities > Pfizer > Symbiq Infusion System

DATE CVE VULNERABILITY TITLE RISK
2019-03-23 CVE-2015-3965 Permissions, Privileges, and Access Controls vulnerability in Pfizer Symbiq Infusion System Firmware 3.13
Hospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.
network
low complexity
pfizer CWE-264
critical
9.0